Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    elagolix uterine fibroids
Show Display Options
Rank Status Study
1 Enrolling by invitation An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Elagolix;   Drug: Estradiol/Norethindrone Acetate
2 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Elagolix + Estradiol/Norethindrone Acetate
3 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Estradiol/Norethindrone Acetate
4 Completed Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Conditions: Heavy Uterine Bleeding;   Uterine Fibroids
Interventions: Other: Placebo;   Drug: Elagolix, elagolix sodium;   Drug: Elagolix Dose 1 plus estradiol/norethindrone acetate;   Drug: Elagolix Dose 2 plus estradiol;   Drug: Elagolix Dose 2 plus cyclical progesterone
5 Completed Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding;   Uterine Fibroids
Interventions: Other: Placebo;   Drug: Elagolix;   Drug: Estradiol/norethindrone acetate, E2/NETA;   Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2;   Drug: Estradiol/norethindrone acetate

Study has passed its completion date and status has not been verified in more than two years.